Lu Y - Search Results

1

Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy.

Lu Y, Wang Q, Yi Q. Lu Y, et al. Oncoimmunology. 2014 Apr 29;3:e28542. doi: 10.4161/onci.28542. eCollection 2014. Oncoimmunology. 2014. PMID: 25054087 Free PMC article.

2

CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma.

Hong S, Qian J, Li H, Yang J, Lu Y, Zheng Y, Yi Q. Hong S, et al. Among authors: lu y. Cancer Immunol Immunother. 2012 Apr;61(4):561-71. doi: 10.1007/s00262-011-1123-2. Epub 2011 Oct 15. Cancer Immunol Immunother. 2012. PMID: 22002243 Free PMC article.

3

Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.

Qian J, Zheng Y, Zheng C, Wang L, Qin H, Hong S, Li H, Lu Y, He J, Yang J, Neelapu S, Kwak LW, Hou J, Yi Q. Qian J, et al. Among authors: lu y. Blood. 2012 Jan 5;119(1):161-9. doi: 10.1182/blood-2011-07-368472. Epub 2011 Nov 2. Blood. 2012. PMID: 22049519 Free PMC article.

4

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.

Zheng Y, Yang J, Qian J, Zhang L, Lu Y, Li H, Lin H, Lan Y, Liu Z, He J, Hong S, Thomas S, Shah J, Baladandayuthapani V, Kwak LW, Yi Q. Zheng Y, et al. Among authors: lu y. J Mol Med (Berl). 2012 Jun;90(6):695-706. doi: 10.1007/s00109-011-0849-9. Epub 2011 Dec 30. J Mol Med (Berl). 2012. PMID: 22207485 Free PMC article.

5

Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.

Wang L, Zhao Y, Qian J, Sun L, Lu Y, Li H, Li Y, Yang J, Cai Z, Yi Q. Wang L, et al. Among authors: lu y. Cancer. 2013 Feb 15;119(4):782-91. doi: 10.1002/cncr.27792. Epub 2012 Aug 22. Cancer. 2013. PMID: 22915070 Free PMC article.

6

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Hong S, Li H, Qian J, Yang J, Lu Y, Yi Q. Hong S, et al. Among authors: lu y. Clin Exp Immunol. 2012 Nov;170(2):167-77. doi: 10.1111/j.1365-2249.2012.04642.x. Clin Exp Immunol. 2012. PMID: 23039887 Free PMC article.

7

Th9 cells promote antitumor immune responses in vivo.

Lu Y, Hong S, Li H, Park J, Hong B, Wang L, Zheng Y, Liu Z, Xu J, He J, Yang J, Qian J, Yi Q. Lu Y, et al. J Clin Invest. 2012 Nov;122(11):4160-71. doi: 10.1172/JCI65459. Epub 2012 Oct 15. J Clin Invest. 2012. PMID: 23064366 Free PMC article.

8

p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.

He J, Liu Z, Zheng Y, Qian J, Li H, Lu Y, Xu J, Hong B, Zhang M, Lin P, Cai Z, Orlowski RZ, Kwak LW, Yi Q, Yang J. He J, et al. Among authors: lu y. Cancer Res. 2012 Dec 15;72(24):6393-402. doi: 10.1158/0008-5472.CAN-12-2664. Epub 2012 Oct 11. Cancer Res. 2012. PMID: 23066034 Free PMC article.

9

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells.

Wang L, Qian J, Lu Y, Li H, Bao H, He D, Liu Z, Zheng Y, He J, Li Y, Neelapu S, Yang J, Kwak LW, Yi Q, Cai Z. Wang L, et al. Among authors: lu y. Haematologica. 2013 Sep;98(9):1458-66. doi: 10.3324/haematol.2012.071340. Epub 2013 Mar 18. Haematologica. 2013. PMID: 23508008 Free PMC article.

10

Utilizing T_H9 cells as a novel therapeutic strategy for malignancies.

Lu Y, Yi Q. Lu Y, et al. Oncoimmunology. 2013 Mar 1;2(3):e23084. doi: 10.4161/onci.23084. Oncoimmunology. 2013. PMID: 23802062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,406 results

Search Page

Filters